Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC Anti-CTLA-4/CD152 Antibody (Ipilimumab) 5mg
Supplier: Apexbio Technology LLC F12215
Ipilimumab (CAS 477202-00-9) is a fully human monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4/CD152) an inhibitory receptor expressed on activated T cells It is designed to block the interaction between CTLA-4 and its ligands CD80/CD86 thereby modulating inhibitory signaling pathways affecting T cell-mediated immune responses Ipilimumab exerts its biological activity primarily through specific binding to CTLA-4 thus regulating immune checkpoint signaling Based on these pharmacological properties Ipilimumab holds research potential in studies focusing on CTLA-4-mediated immune regulation and investigative models addressing unresectable or metastatic melanoma
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?